A glutamate-substituted mutant mimics the phosphorylated and active form of guanylyl cyclase-A

Neil M Otto, William G. McDowell, Deborah M Dickey, Lincoln R Potter

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Multisite phosphorylation is required for activation of guanylyl cyclase (GC)-A, also known as NPR-A or NPR1, by cardiac natriuretic peptides (NPs). Seven chemically identified sites (Ser- 487, Ser-497, Thr-500, Ser-502, Ser-506, Ser-510, and Thr-513) and one functionally identified putative site (Ser-473) were reported. Single alanine substitutions for Ser-497, Thr-500, Ser-502, Ser-506, and Ser-510 reduced maximal velocity (Vmax), whereas glutamate substitutions had no effect or increased Vmax. Ala but not Glu substitution for Ser-497 increased the Michaelis constant (Km) approximately 400%. A GC-A mutant containing Glu substitutions for all seven chemically identified sites (GC-A-7E) had a Km approximately 10-fold higher than phosphorylated wild-type (WT) GC-A, but one additional substitution for Ser-473 to make GC-A-8E resulted in the same Vmax, Km, and EC50 as the phosphorylated WT enzyme. Adding more glutamates to make GC-A-9E or GC-A-10E had little effect on activity, and sequential deletion of individual glutamates in GC-A- 8E progressively increased the Km. Double Ala substitutions for Ser-497 and either Thr-500, Ser-510 or Thr-513 in WT-GC-A increased the Km 23- to 70-fold but the same mutations in GC-A- 8E only increased the Km 8-fold, consistent with one site affecting the phosphorylation of other sites. Phosphate measurements confirmed that single-site Ala substitutions reduced receptor phosphate levels more than expected for the loss of a single site. We conclude that a concentrated region of negative charge, not steric properties, resulting from multiple interdependent phosphorylation sites is required for a GC-A conformation capable of transmitting the hormone binding signal to the catalytic domain.

Original languageEnglish (US)
Pages (from-to)67-74
Number of pages8
JournalMolecular Pharmacology
Issue number1
StatePublished - Jul 2017

Bibliographical note

Funding Information:
This research was supported in part by the National Institutes of Health National Institute of General Medical Sciences [Grant R01GM098309] and by a grant from the Fund for Science.

Publisher Copyright:
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics.


Dive into the research topics of 'A glutamate-substituted mutant mimics the phosphorylated and active form of guanylyl cyclase-A'. Together they form a unique fingerprint.

Cite this